Parkinson-kór: vizsgálatok itt: Hollandia
35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
- Where
- Amsterdam, 's-Hertogenbosch, Zwolle
- Életkor
- 40 év to 85 év
- People
- 474 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07781644 · EU 2025-524064-37-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Where
- Amsterdam, 's-Hertogenbosch, Zwolle
- Életkor
- 50 év to 85 év
- People
- 900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00 - No phaseTaking peopleNon-invasive Brain Stimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
- Where
- Amsterdam
- People
- 20
- Run by
- Amsterdam UMC
See details and how to joinNCT06399731 - No phaseTaking peopleSTIMPulseControl Ancillary Speech Study
- Where
- Amsterdam
- Életkor
- 18 év to 70 év
- People
- 60 worldwide
- Run by
- Steffen Paschen
See details and how to joinNCT06561919 - 2/3. fázisTaking peopleA Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Where
- Amsterdam, Groningen, Leiden, Nijmegen, 's-Hertogenbosch
- Életkor
- 40 év to 80 év
- People
- 550 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06976268 · EU 2025-521113-13-00 - 1. fázisTaking peopleA study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.
- Where
- Amsterdam, Groningen, Nijmegen, 's-Hertogenbosch, Zwolle
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2024-511110-21-00 · EU 2024-511110-21-00 - No phaseTaking peopleBilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl
- Where
- Amsterdam
- Életkor
- 18 év to 70 év
- People
- 60 worldwide
- Run by
- University of Kiel
See details and how to joinNCT06498349 - 1. fázisTaking peopleA Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Where
- Groningen, Nijmegen
- Életkor
- 30 év to 80 év
- People
- 124 worldwide
- Run by
- Prevail Therapeutics
See details and how to joinNCT06565195 · EU 2024-513411-27-00 - No phaseTaking peopleSlow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- Where
- Nijmegen
- Életkor
- 50 év and over
- People
- 600 worldwide
- Run by
- Radboud University Medical Center
See details and how to joinNCT06993142 - 1. fázisTaking peopleFirst-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
- Where
- Leiden
- Életkor
- 50 év to 80 év
- People
- 46 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07216066 · EU 2025-521431-37-00 - No phaseNot yet taking people in HollandiaClosed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease
- Where
- Amsterdam, Maastricht
- People
- 30
- Run by
- HagaZiekenhuis
See details and how to joinNCT07105280 - 2. fázisNot yet taking people in HollandiaA Phase 2 study of VQ-101 in participants with Parkinson’s disease and GBA1 mutation
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 16 worldwide
- Run by
- Vanqua Bio Inc.
See details and how to join2026-525848-15-00 · EU 2026-525848-15-00 - No phaseTaking peopleSlow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
- Where
- Nijmegen
- Életkor
- 50 év and over
- People
- 110
- Run by
- Radboud University Medical Center
See details and how to joinNCT06193252 - No phaseTaking peopleResearch Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease
- Where
- Leiden
- Életkor
- 18 év to 80 év
- People
- 200
- Run by
- Vertero Therapeutics
See details and how to joinNCT07175922 - 2. fázisTaking peopleA Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease
- Where
- Groningen
- Életkor
- 40 év and over
- People
- 45
- Run by
- GEN İlaç ve Sağlık Ürünleri A.Ş.
See details and how to joinNCT07322887 · EU 2025-524674-42-00 - No phaseTaking peoplePPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Where
- Nijmegen
- Életkor
- 30 év and over
- People
- 4500 worldwide
- Run by
- Michael J. Fox Foundation for Parkinson's Research
See details and how to joinNCT04477785 - 1. fázisTaking peopleResearch into the safety of a new agent (NRG5051) in healthy adults and patients with Parkinson's disease or ALS
- Where
- Leiden
- Életkor
- 18 év and over
- People
- 118
- Run by
- Nrg Therapeutics Limited
See details and how to join2025-523872-22-00 · EU 2025-523872-22-00 - 3. fázisTaking peoplePharmacologically modulating the noradrenergic arousal system to reduce freezing of gait in Parkinson’s disease: a multi-center and multi-modal approach.
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 20
- Run by
- Stichting Radboud universitair medisch centrum
See details and how to join2024-516756-18-00 · EU 2024-516756-18-00 - 2. fázisTaking peoplePsilocybin Therapy for Psychological Distress in Palliative Patients
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 108 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01 - 1. fázisTaking peopleResearch Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease
- Where
- Leiden
- Életkor
- 18 év to 80 év
- People
- 84
- Run by
- Vertero Therapeutics
See details and how to joinNCT07310264 · EU 2025-523254-14-00 - No phaseTaking peopleCue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease
- Where
- Amsterdam, Nijmegen
- People
- 84
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06416345 - 3. fázisTaking peoplePharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 60
- Run by
- Radboud University Medical Center
See details and how to joinNCT07316296 - 2. fázisTaking peopleManagement of Parkinson's disease if levodopa is broken down prematurely
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 81
- Run by
- Stichting Radboud University Medical Center
See details and how to join2024-510629-24-00 · EU 2024-510629-24-00 - No phaseTaking peopleAdaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
- Where
- Amsterdam, Maastricht, The Hague
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT06909045 - 2. fázisNot yet taking people in HollandiaEvaluation of [18F]MC225 to measure P-glycoprotein function in neurodegenerative disease
- Where
- Groningen
- Életkor
- 18 év and over
- People
- 30
- Run by
- Universitair Medisch Centrum Groningen
See details and how to join2024-518865-85-00 · EU 2024-518865-85-00